Robert H. Springer

Purine analog inhibitors of xanthine oxidase ‐ structure activity relationships and proposed binding of the molybdenum cofactor

Roland K. Robins, Ganapathi R. Revankar, Darrell E. O'Brien et al. · Journal of Heterocyclic Chemistry · 1985 · 104 citations

New Phenyl, Molybdenum Cofactor, Pharmacotherapy +16

2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents

Thomas Novinson, Robert H. Springer, D. E. O'BRIEN et al. · Journal of Medicinal Chemistry · 1982 · 62 citations · Full text

Medicinal Chemistry, Camp Pde, Heart Rate +14

Pyrimidines. I. Synthesis of Pyrimidinethiols^1,2

Henry C. Koppel, Robert H. Springer, Roland K. Robins et al. · The Journal of Organic Chemistry · 1961 · 44 citations

Molecular Sciences, Bioorganic Chemistry, Chemical Analysis +13

Synthesis and antitrichomonal activity of certain pyrazolo[1,5-a]pyrimidines

K. SENGA, Thomas Novinson, Robert H. Springer et al. · Journal of Medicinal Chemistry · 1975 · 42 citations

Nuclease Resistance of Oligonucleotides Containing the Tricyclic Cytosine Analogues Phenoxazine and 9-(2-Aminoethoxy)-Phenoxazine (“G-clamp”) and Origins of Their Nuclease Resistance Properties

Martin A. Maier, Janet M. Leeds, Guity Balow et al. · Biochemistry · 2001 · 37 citations

Nucleic Acid Chemistry, Bioorganic Chemistry, Nuclease Resistance +12